Axar.az
UP
17 November 2019


Congo to start using Johnson & Johnson Ebola vaccine

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

Health authorities in the Democratic Republic of Congo will introduce a Johnson & Johnson Ebola vaccine in November in the country’s eastern provinces, to counter the current outbreak, they said.

Axar.az reports citing Reuters that the J&J vaccine will complement another vaccine manufactured by Merck, which has been administered to more than 225,000 people. It requires two injections eight weeks apart, unlike the Merck vaccine, which requires a single shot.

The first batch of 500,000 doses of the J&J vaccine should arrive in Congo next week, the authorities said in a statement. The inoculation process will start in Goma in early November and then be extended to other provinces.

Congolese health authorities had announced the deployment of the vaccine last month but had not specified when the campaign will take place.

Since it first started in August 2018, the Ebola outbreak has killed more than 2,100 people, second only to the 2013-16 outbreak in West Africa that killed more than 11,300.

Date
2019.10.14 / 18:53
Author
Axar.az
Comments
See also

Online shopping addiction is a mental health condition

WHO to sterilize mosquitos in the fight against disease

BRICS countries to establish a Human Milk Bank network

The rollout of Ebola vaccine begins in Congo

Diabetes forecast to affect 700 million by 2045

Ebola vaccine approved as second jab trialled

New Zealanders to vote in a referendum on euthanasia

Google shares private health data of millions

Pneumonia kills a child every 39 seconds - report

Two cannabis approved for NHS

Latest
 
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla